IRIS Accounts Production v24.2.0.383 08472809 Board of Directors 1.4.23 31.3.24 31.3.24 0 0 false true false false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh084728092023-03-31084728092024-03-31084728092023-04-012024-03-31084728092022-03-31084728092022-04-012023-03-31084728092023-03-3108472809ns15:EnglandWales2023-04-012024-03-3108472809ns14:PoundSterling2023-04-012024-03-3108472809ns10:Director12023-04-012024-03-3108472809ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3108472809ns10:SmallEntities2023-04-012024-03-3108472809ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3108472809ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3108472809ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3108472809ns10:FullAccounts2023-04-012024-03-310847280912023-04-012024-03-3108472809ns10:OrdinaryShareClass22023-04-012024-03-3108472809ns10:OrdinaryShareClass32023-04-012024-03-3108472809ns10:Director22023-04-012024-03-3108472809ns10:RegisteredOffice2023-04-012024-03-3108472809ns5:CurrentFinancialInstruments2024-03-3108472809ns5:CurrentFinancialInstruments2023-03-3108472809ns5:ShareCapital2024-03-3108472809ns5:ShareCapital2023-03-3108472809ns5:FurtherSpecificReserve3ComponentTotalEquity2024-03-3108472809ns5:FurtherSpecificReserve3ComponentTotalEquity2023-03-3108472809ns5:RetainedEarningsAccumulatedLosses2024-03-3108472809ns5:RetainedEarningsAccumulatedLosses2023-03-3108472809ns5:NetGoodwill2023-04-012024-03-3108472809ns5:NetGoodwill2023-03-3108472809ns5:NetGoodwill2024-03-3108472809ns5:NetGoodwill2023-03-3108472809ns5:ComputerEquipment2023-03-3108472809ns5:ComputerEquipment2024-03-3108472809ns5:ComputerEquipment2023-03-3108472809ns5:CostValuation2023-03-3108472809ns5:AdditionsToInvestments2024-03-3108472809ns5:DisposalsRepaymentsInvestments2024-03-3108472809ns5:RevaluationsIncreaseDecreaseInInvestments2024-03-3108472809ns5:CostValuation2024-03-3108472809ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3108472809ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3108472809ns10:OrdinaryShareClass22024-03-3108472809ns10:OrdinaryShareClass32024-03-31
REGISTERED NUMBER: 08472809 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2024

FOR

JAKEWAYS SURGICAL SERVICES LIMITED

JAKEWAYS SURGICAL SERVICES LIMITED (REGISTERED NUMBER: 08472809)

CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31st March 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


JAKEWAYS SURGICAL SERVICES LIMITED

COMPANY INFORMATION
for the Year Ended 31st March 2024







DIRECTORS: Mr M S Jakeways
Mrs D Jakeways





REGISTERED OFFICE: 100 Barbirolli Square
Manchester
United Kingdom
M2 3BD





REGISTERED NUMBER: 08472809 (England and Wales)





ACCOUNTANTS: Xeinadin
100 Barbirolli Square
Manchester
M2 3BD

JAKEWAYS SURGICAL SERVICES LIMITED (REGISTERED NUMBER: 08472809)

BALANCE SHEET
31st March 2024

2024 2023
Notes £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 - -
Investments 6 1,568,668 1,462,332
1,568,668 1,462,332

CURRENT ASSETS
Debtors 7 18,866 16,302
Cash at bank 107,127 102,984
125,993 119,286
CREDITORS
Amounts falling due within one year 8 (577,699 ) (607,111 )
NET CURRENT LIABILITIES (451,706 ) (487,825 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,116,962

974,507

CAPITAL AND RESERVES
Called up share capital 9 100 100
Fair value reserve 10 5,301 -
Retained earnings 1,111,561 974,407
SHAREHOLDERS' FUNDS 1,116,962 974,507

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30th September 2024 and were signed on its behalf by:




Mr M S Jakeways - Director


JAKEWAYS SURGICAL SERVICES LIMITED (REGISTERED NUMBER: 08472809)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31st March 2024


1. STATUTORY INFORMATION

Jakeways Surgical Services Ltd is a private company limited by share capital, incorporated in England and Wales, registration number 08472809. The address of the registered office is 100 Barbirolli Square, Manchester, United Kingdom, M2 3BD. The principle place of business is 1 Lincoln Road, Rochford, Essex, SS4 3AF.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover represents amounts recognised by the company in respect of goods and services supplied, exclusive of Value Added Tax and trade discounts. Turnover principally consists of fees for medical consultancy services, which are recognised at the point of which the services are provided.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2013, has been amortised evenly over its estimated useful life of five years.

Tangible fixed assets
Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses.

Depreciation on tangible fixed assets is charged to the profit and loss so as to write off their value, over their
estimated useful lives, using the following methods:

Computer Equipments- 33% on cost

At each balance sheet date, the Company reviews the carrying amounts of its tangible fixed assets to determine whether there is any indication that any items of tangible fixed assets have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss, if any. Where it is not possible to estimate the recoverable amount of the asset, the Company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

If the recoverable amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount. Impairment loss is recognised as an expense immediately.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

JAKEWAYS SURGICAL SERVICES LIMITED (REGISTERED NUMBER: 08472809)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31st March 2024


2. ACCOUNTING POLICIES - continued

Investments
Investments are shown at the most recent valuation. Any aggregate surplus or deficit arising from changes in market value is transferred to a revaluation reserve.

Trade and other debtors
Basic financial assets, including trade and other debtors, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment.

Trade and other creditors
Basic financial liabilities, including trade and other creditors, loans from third parties and loans from related parties, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Such instruments are subsequently carried at amortised cost using the effective interest method, less any impairment.

Cash and cash equivalents
Cash and cash equivalents are represented by cash at bank and in hand.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1st April 2023
and 31st March 2024 25,000
AMORTISATION
At 1st April 2023
and 31st March 2024 25,000
NET BOOK VALUE
At 31st March 2024 -
At 31st March 2023 -

5. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1st April 2023
and 31st March 2024 490
DEPRECIATION
At 1st April 2023
and 31st March 2024 490
NET BOOK VALUE
At 31st March 2024 -
At 31st March 2023 -

JAKEWAYS SURGICAL SERVICES LIMITED (REGISTERED NUMBER: 08472809)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31st March 2024


6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST OR VALUATION
At 1st April 2023 1,462,332
Additions 341,035
Disposals (240,000 )
Revaluations 5,301
At 31st March 2024 1,568,668
NET BOOK VALUE
At 31st March 2024 1,568,668
At 31st March 2023 1,462,332

Cost or valuation at 31st March 2024 is represented by:

Other
investments
£   
Valuation in 2024 1,568,668

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 18,866 16,302

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 2,172 1,820
Taxation and social security 44,847 33,387
Other creditors 530,680 571,904
577,699 607,111

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
90 Ordinary A £1 90 90
10 Ordinary B £1 10 10
100 100

JAKEWAYS SURGICAL SERVICES LIMITED (REGISTERED NUMBER: 08472809)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31st March 2024


10. RESERVES
Fair
value
reserve
£   
Fair value reserve 5,301

At 31st March 2024 5,301